基本信息
views: 2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Tony Ng is the Joint Head of School of Cancer & Pharmaceutical Sciences, Richard Dimbleby Professor of Cancer Research, King’s College London and Professor of Molecular Oncology at University College London (UCL) Cancer Institute. He has a mix of training/expertise in medicine, immunology, cancer cell biology, biochemistry, optical imaging and cell biophysics. Most recently he has also expanded his imaging repertoire to the development of radionuclide imaging tracers against targeted molecules.
He has directed the CRUK-funded KCL-UCL Comprehensive Cancer Imaging Centre since 2008. The central mission is to deliver a coherent & translationally oriented Imaging-OMIC combination approach for clinical studies. Tissue and circulating exosome-based omics have been combined successfully with the use of clinical imaging to individualise cancer treatment, especially in the context of human epidermal growth factor receptor (HER) targeted treatments. His team has recently shown in a Phase II head and neck anti-HER cancer therapy trial, that exosomal HER receptor measurements, which present a new way of following this receptor rewiring mechanism, can contribute significantly to the prediction of favourable treatment response as measured by CT (RECIST) (ASCO. (2018), Journal of Clinical Oncology 36: Suppl 6043).
In addition, he leads the Tumour Immunology imaging project within the Breast Cancer Now Unit at KCL. He is also the Joint lead for the Cross-Disciplinary approaches enhancing biotherapeutics Theme of the newly formed UCL-Barts-King’s-Crick CRUK Major Centre/City of London Centre. His team demonstrated in breast and lung cancers that exosomal PD-L1 is part of a tightly regulated immune surveillance mechanism linking exosomal measurements in the blood to direct cell-cell immunosuppressive interactions (Cell reports. 2018;24:630-641).
He has directed the CRUK-funded KCL-UCL Comprehensive Cancer Imaging Centre since 2008. The central mission is to deliver a coherent & translationally oriented Imaging-OMIC combination approach for clinical studies. Tissue and circulating exosome-based omics have been combined successfully with the use of clinical imaging to individualise cancer treatment, especially in the context of human epidermal growth factor receptor (HER) targeted treatments. His team has recently shown in a Phase II head and neck anti-HER cancer therapy trial, that exosomal HER receptor measurements, which present a new way of following this receptor rewiring mechanism, can contribute significantly to the prediction of favourable treatment response as measured by CT (RECIST) (ASCO. (2018), Journal of Clinical Oncology 36: Suppl 6043).
In addition, he leads the Tumour Immunology imaging project within the Breast Cancer Now Unit at KCL. He is also the Joint lead for the Cross-Disciplinary approaches enhancing biotherapeutics Theme of the newly formed UCL-Barts-King’s-Crick CRUK Major Centre/City of London Centre. His team demonstrated in breast and lung cancers that exosomal PD-L1 is part of a tightly regulated immune surveillance mechanism linking exosomal measurements in the blood to direct cell-cell immunosuppressive interactions (Cell reports. 2018;24:630-641).
Research Interests
Papers共 264 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
Anjali Chander,Jacopo Iacovacci,Aize Pellon, Rhadika Kataria,Anita Grigoriadis,John Maher,Cynthia Sears, Gilad Bachrach,Teresa Guerrero Urbano,Mary Lei,Imran Petkar,Anthony Kong,
Cancer communications (London, England) (2024)
Ali Abdulnabi Suwaidan,Anna Pasto, Caitlin McCarthy,Teng Pan,Jinhai Deng,Luigi Dolcetti,Giovanna Alfano,Rami Mustapha,James Monypenny,Martin Forster,Tony Ng
Cancer Researchno. 6_Supplement (2024): 2040-2040
Emily Sible, Gregory Weissman, Salome Amoyal,Guillaume Roblot,Marie Marotel,Michelle Ainouze, Rémi Pescarmona, Nathalie Bendriss-Vermare,Cheryl Gillet, Amie Ceesay,Marie Cecile Michallet,Christophe Caux,
biorxiv(2024)
Oral oncology (2024): 106717-106717
biorxiv(2023)
Patriek Jurrius,Omar Darwish,Daniel Fovargue,Belul Shifa, Kathleen A. Welsh, Joanna Bell, Sarah-Jane Hamilton,J. David Spence,Giacomo Annio,Renee Miller,Marian Troelstra,Ashutosh Kothari,
openalex(2023)
bioRxiv (Cold Spring Harbor Laboratory) (2023)
PEDIATRIC BLOOD & CANCER (2023)
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn